Jyong Biotech (MENS) Receivables - Affiliates (2024 - 2025)
Jyong Biotech's (MENS) quarterly Receivables - Affiliates came in at $628000.0 in Q2 2025, little changed quarter-over-quarter from $628000.0 in Q4 2024.
Jyong Biotech (MENS) Receivables - Affiliates (2024 - 2025) Analysis & Trends
Jyong Biotech's Receivables - Affiliates history runs 2 years deep, the most recent figure standing at $628000.0 for Q2 2025.
- On a quarterly basis, Receivables - Affiliates changed N/A year-over-year to $628000.0 in Q2 2025; TTM through Jun 2025 was $628000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $628000.0, changed N/A from the prior year.
- Receivables - Affiliates was little changed at $628000.0 in Q2 2025 per MENS's latest filing, from $628000.0 in the prior quarter.
- Across five years, Receivables - Affiliates topped out at $628000.0 in Q4 2024 and bottomed at $628000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Affiliates (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Jyong Biotech | 197.86 Mn | 197.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 628,000.00 |
| Jun 30, 2025 | 628,000.00 |
| Dec 31, 2024 | 628,000.00 |
| Dec 31, 2024 | 628,000.00 |